Chu et al., 2006 - Google Patents
Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy.Chu et al., 2006
- Document ID
- 3907735882861232913
- Author
- Chu E
- Einhorn L
- Lefebvre P
- Publication year
- Publication venue
- The journal of supportive oncology
External Links
Snippet
In a large, 16-week, prospective study of 2,964 anemic patients with various cancers undergoing chemotherapy, once-weekly subcutaneous administration of 40,000 U of epoetin alfa, with potential escalation to 60,000 U, increased hemoglobin (Hgb) levels …
- 108010074604 Epoetin Alfa 0 title abstract description 11
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cats | New developments in systemic chemotherapy in advanced colorectal cancer. | |
| Chu et al. | Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy. | |
| Hadoux et al. | Lung cancer in never smoker: Epidemiology, molecular profiles and treatment | |
| Bachmann | Epoetin alfa use in gynecology. Past, present and future. | |
| Cemazar et al. | Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice. | |
| Guillamo | Anti-angiogenic strategies in glioblastoma | |
| Mahon et al. | Peripheral Neuropathy: Common Side Effect. | |
| Shasha et al. | Weekly epoetin alfa treatment of anemia in patients with cancer not undergoing therapy. | |
| Vanhoefer | Novel molecular approaches in the therapy of advanced colorectal carcinoma | |
| Pautier et al. | Systemic therapy for advanced endometrial cancer | |
| Sessa et al. | Dose-finding study of paclitaxel and cyclophosphamide in women with advanced breast cancer. | |
| Heger et al. | Modern nanomedicine in treatment of lung carcinomas | |
| Shamseddine et al. | Cisplatin and vinorelbine (PVn) for the treatment of advanced breast cancer: 10 years of experience. | |
| Ishida | Recent progress of diagnosis and treatment in NK cell neoplasms | |
| Psyrri et al. | Small cell lung cancer: strategies to optimize chemotherapy response. | |
| Wu et al. | Clinical observation on effects of Yisui Shengxue Granule in treating 156 patients with beta-thalassemia | |
| Mucsi | Treatment of patients with chronic lymphocytic leukemia | |
| Drabko et al. | Megachemotherapy and autologous hematopoietic stem cell transplantation in children with solid tumours excluding neuroblastoma--experience of Polish paediatric centres | |
| Qiao et al. | Curative effect of human umbilical cord mesenchymal stem cells for treatment of acute graft-versus-host disease of children after allo-HSCT | |
| Katoh et al. | Changes in serum soluble IL-2 receptors (sIL-2R) and immunosuppressive acidic protein (IAP) associated with chemotherapy for lung cancer. | |
| Wolchok et al. | Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy. | |
| Hasanova et al. | Efficiency of recombinant erythropoietin administration in hemoglobinopathy H. | |
| Graeven et al. | Colorectal cancer: current treatment options | |
| Yamamoto et al. | Chronopharmacology of etoposide given by low dose prolonged infusion in lung cancer patients. | |
| Lin et al. | An experimental study on effect of recombinant human growth hormone alone and combined with 5-flurouracil on tumor bearing mice |